SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-040276
Filing Date
2013-05-10
Accepted
2013-05-10 16:11:00
Documents
3
Period of Report
2013-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-12075_18k.htm 8-K 28260
2 EX-99.1 a13-12075_1ex99d1.htm EX-99.1 7272
3 GRAPHIC g120751mmi001.jpg GRAPHIC 5246
  Complete submission text file 0001104659-13-040276.txt   44126
Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 13833551
SIC: 2836 Biological Products, (No Diagnostic Substances)